Globally operating pharmaceutical company
Temporary assignment for 12-24 months
About Our Client
For our client, a globally renowned pharmaceutical company in the Basel area, we are seeking a Quality Assurance (GMP&Clinical) professional to strengthen the team in 2026 in support of Phase 3 development activities. The contract duration is 12-24 months and is open to candidates with 5+ years of relevant experience across different seniority levels.
Depending on the selected candidate's performance and motivation, the possibility of an extension or a permanent take over.
Job Description
Depending on the candidate`s seniority, the incumbent will provide Quality Assurance oversight for Phase 3 clinical development, ensuring GMP and GCP compliance for clinical trial material and trial execution (small molecules drugs).
Lead / Support establishment and maintenance of the Quality Management System appropriate for Phase 3
Own / Contribute to GMP oversight of drug substance, drug product, packaging, labeling, and testing activities
Manage / Coordinate batch record review, lot disposition, and clinical supply release
Lead / Support deviation, CAPA, and change control activities impacting Phase 3 material
Oversee / Participate in vendor and CDMO quality oversight and audits
Ensure / Support inspection readiness for GMP and GCP inspections
Lead / Support Quality input to stability programs and expiry management
Approve / Review quality documentation depending on delegated authority
The Successful Applicant
In order to be considered for the role, the selected candidate must have:
Degree in Life Sciences disciplines
Relevant experience in QA phase 3 (small molecules):
~5-7 years: Executes QA activities, supports audits/inspections, manages assigned systems
~8-10 years: Leads QA activities, acts as primary QA contact for Phase 3 program
10+ years: Owns QA strategy, leads inspections, accountable for quality risk
Strong communication skills in English
Passion for Drug Development (small molecules)
What's on Offer
The selected candidate will be part of a dynamic team in an international environment and actively contribute to shape, develop, and drive the market authorization of innovative drugs. Hybrid work model (3 days onsite). Extension or take-over possibility.
#J-18808-Ljbffr